Aier Eye Hospital Group (300015.SZ)

Overall impact
B (63)

Commentary

Aier Eye Hospital Group is a strong overall performer. With a 'B' rating of 62.5 for overall impact (68th percentile compared to all companies), Aier Eye Hospital Group ranks 22nd out of 39 industry peers, behind Concord Medical Services, Sunlink Health Systems, New Frontier Health and 18 others, and ahead of Oak Street Health, Orpea, Hygeia Healthcare and 14 others. On top material causes for Aier Eye Hospital Group's industry (Healthcare Providers), Aier Eye Hospital Group performs well in Technology Innovation (95.2 score) and Improved Mental Health (95.8) and performs poorly in No Violence Against Women (35.1 score).
Impact
Cause 300015.SZ
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

Aier Eye Hospital Group

Employees
42,817
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Facilities
SASB industry
Health Care Delivery
Headquarters
China
Share classes
300015.SZ
Description
Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates ophthalmic hospitals in mainland China, Europe, the United States, Hong Kong, and Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.
Material causes
Ethos considers the following causes material for Aier Eye Hospital Group, based on its industry sub-industry Health Care Facilities. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.